Di(2,5,8,11,14,17,20,23-octaoxapentacosan-25-yl)amine

Catalog No. :
ACBEOM401
CAS No. :
2055013-64-2
Molecular Formula :
C34H71NO16
Molecular Weight :
749.93

IUPAC Name:di(2,5,8,11,14,17,20,23-octaoxapentacosan-25-yl)amine

Di(2,5,8,11,14,17,20,23-octaoxapentacosan-25-yl)amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$71.00Login to see priceIn stockInquiry
1g95%$220.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDi(2,5,8,11,14,17,20,23-octaoxapentacosan-25-yl)amine
IUPAC Namedi(2,5,8,11,14,17,20,23-octaoxapentacosan-25-yl)amine
MDL No.MFCD28015763
Molecular FormulaC34H71NO16
Molecular Weight749.93
SMILESCOCCOCCOCCOCCOCCOCCOCCOCCNCCOCCOCCOCCOCCOCCOCCOCCOC
InChI KeyMNMWPNXARNOFIU-UHFFFAOYSA-N
SynonymNH-(m-PEG8)2;NH-bis(m-PEG8);(mPEG8)2-NH;3,6,9,12,15,18,21,24-Octaoxapentacosan-1-amine, N-3,6,9,12,15,18,21,24-octaoxapentacos-1-yl-;(mPEG8)2-NH/3,6,9,12,15,18,21,24-Octaoxapentacosan-1-amine, N-3,6,9,12,15,18,21,24-octaoxapentacos-1-yl-
CAS No.2055013-64-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBEOM401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMYRA420 route compound structure diagram
    ACMYRA4201056881-04-9 In Stock
  2. Plus
  3. ACCWSQ572 route compound structure diagram
    ACCWSQ572869718-81-0 In Stock
  4. Then
  5. ACBEOM401 route product structure diagram
    ACBEOM4012055013-64-2 In Stock
Inquiry

2. ACBEOM401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBEOM401 route product structure diagram
    ACBEOM4012055013-64-2 In Stock
Inquiry

Comments (0)